Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative Colitis

PHASE2TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

February 25, 2021

Study Completion Date

December 14, 2021

Conditions
Ulcerative Colitis
Interventions
DRUG

Tilpisertib

Tablets administered orally once daily

DRUG

Placebo

Tablets administered orally once daily

Trial Locations (49)

1090

Medizinische Universitat Wien Klinik fur Innere Medizin III/Abt. fur Gastroenterologie and Hepatologie, Vienna

3012

Gastroenterologische Praxis Balsiger, Seibold & Partner/Crohn-Colitis-Zentrum, Bern

3065

St Vincent's Hospital Melbourne, Fitzroy

3124

Emeritus Research, Melbourne

4558

Coastal Digestive Health, Maroochydore

5011

The Queen Elizabeth Hospital, Woodville

6020

Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin I, Innsbruck

8091

Universitätsspital Zürich/Klinik für Gastroenterologie und Hepatologie, Zurich

20089

Istituto Clinico Humanitas, Rozzano

21079

CHU de Dijon Bourgogne, Dijon

24105

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik fur Innere Medizin I, Haus C, Haus K3, Kiel

29118

Gastroenterology Associates of Orangeburg, Orangeburg

30024

Atlanta Gastroenterology Specialists, PC, Suwanee

30060

Gastrointestinal Specialists of Georgia, Marietta

32127

Advanced Medical Research Center, Port Orange

32256

Encore Borland-Groover Clinical Research, Jacksonville

32423

Gastroenterologische Gemeinschaftspraxis Minden, Minden

33071

Alliance Medical Research, Coral Springs

33144

A Plus Research, Inc, Miami

33322

BRCR Medical Center Inc., Plantation

36305

Gut P.C., dba Digestive Health Specialists of the Southeast, Dothan

38043

Centre Hospitalier Universitaire de Grenoble Alpes, Grenoble

42055

CHU de Saint Etienne, Saint-Etienne

45219

Consultants for Clinical Research, Cincinnati

53225

Allegiance Research Specialists, LLC, Wauwatosa

54511

CHRU de Nancy, Vandœuvre-lès-Nancy

59000

CHRU de Lille - Hôpital Claude Huriez, Lille

64131

Kansas City Research Institute, Kansas City

69495

CHU de Lyon Sud, Pierre-Bénite

71105

Louisiana Research Center, LLC, Shreveport

76092

Texas Digestive Disease Consultants, Southlake

77074

Southwest Clinical Trials, Houston

77429

Allied Digestive Disease Center, Cypress

78212

Clinical Associates in Research Therapeutics of America, LLC, San Antonio

78666

Texas Digestive Disease Consultants, San Marcos

89123

Advanced Biomedical Research of America, Las Vegas

92064

Alliance Clinical Research, Poway

92110

Hopital Beaujon, Clichy

92563

United Medical Doctors, Murrieta

93534

Om Research LLC, Lancaster

37212-1375

Vanderbilt University Medical Center - IBD Clinic, Nashville

V5Z 1M9

Vancouver General Hospital - The Gordon and Leslie Diamond Health Care Centre, Vancouver

35033 Cedex 9

CHRU Pontchaillou, Rennes

31059 cedex 9

Hopital Rangueil, Toulouse

04103

Eugastro GmbH, Leipzig

71-434

Twoja Przychodnia - Szczecinskie Centrum Medyczne, Szczecin

87-100

"GASTROMED Kopon, Zmudzinski i Wsp. Sp. J. Spec. Centrum Gastrologii i Endoskopii, Spec. Gabinety Lekarskie", Torun

50-449

Centrum Medyczne Melita Medical, Wroclaw

CH-3010

Inselspital Bern/Klinik fur Viszerale Chirurgie und Medizin/Bauchzentrum, Bern

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Gilead Sciences

INDUSTRY